While randomised, controlled trials have established the efficacy of the implantable cardioverter defibrillator (ICD) for primary and secondary prevention of life threatening arrhythmias, psychosocial responses remain complex and poorly understood, especially across Europe. There appears to be a greater need to understand differences in the experience of men and women.
Aim:
The aim of this prospective study was to explore differences in psychosocial adjustment over a 12 month period following ICD implantation.
Methods:
Fourteen female and thirty three male device recipients completed a series of questionnaires over a 12 month period. Instruments included a generic and an ICD specific Quality of Life (QOL) measure and the State–Trait Anxiety Inventory.
Results:
Women reported higher levels of anxiety than men at discharge but over time demonstrated a significant improvement such that at 4, 8 and 12 months men were more anxious. Women reported significantly poorer emotional wellbeing at discharge, however by 12 months this was significantly improved with no difference in the perceptions held by men and women. Women consistently across the 12 months worried more than men about the impact of the device on appearance.
Conclusion:
This study confirmed that most individuals adjust positively to the ICD during the first 12 months. Some gender differences in adjustment were evident. Further studies across Europe are warranted to establish gender specific interventions to support men and women as they adapt to life with ICD implants.
Antiarrhythmic Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med1997; 337(22): 1576–1583.
2.
BuxtonAELeeKLFisherJDJosephsonMEPrystowskyENHafleyG. For the Multicentre Unsustained Tachycardia Trial Investigators (MUSTT). A randomised study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med1999; 341: 1882–1890.
3.
ConnollySJGentMRobertsRSDorianPRoyDSheldonRS. Canadian Implantable Defibrillator Study (CIDS): a randomised trial of the implantable cardioverter defibrillator against amiodarone. Circulation2000; 101: 1297–1302.
4.
ConnollySJHallstromAPCappatoRSchronEBKuckKHZipesDP. Meta analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies, Antiarrhythmics vs Implantable Cardioverter Defibrillator Study, Cardiac Arrest Study Hamburg, Canadian Implantable Defibrillator Study. Eur Heart J2000; 21: 2071–2078.
5.
GrimmWAtlerPMaischB. Arrhythmia risk factor stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy: results of MACAS, DEFINITE and SCD-HeFT. Herz2004; 29(3): 348–352.
6.
MossAJZarebaWHallWJKleinHWilberDJCannomDS. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl JMed2002; 346: 877–883.
7.
EpsteinAEDiMarcoJPEllenbogenKAEstesNAFreedmanRAGettesLS. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol2008; 51(21): e1–e62.
8.
PrioriSGAliotEBlomstrom-LundqvistCBossaertLBreithardtGBrugadaP. 2001 task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J2001; 22: 1374–1450.
9.
NICE (National Institute For Clinical Excellence). Implantable Cardioverter Defibrillators (ICDs) for arrhythmias. Review of Technology Appraisal 11. Technology Assessment 95 Available at: http://www.nice.org.uk2006.
10.
ScottPAGormanSAndrewsNPRobertsPRKairaPR. Estimation of requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006). Europace2008; 10: 453–457.
11.
BaingerEMFernslerJI. Perceived quality of life before and after implementation of an internal cardioverter defibrillator. Am J Crit Care1995; 4(1): 36–43.
12.
LuderitzBJungWDeisterAManzM. Patient acceptance of implantable cardioverter defibrillator devices: changing attitudes. Am Heart J1994; 4(2): 1179–1184.
13.
DoughertyCM. Longitudinal recovery following sudden cardiac arrest and internal cardioverter defibrillator implantation: survivors and their families. Am J Crit Care1994; 3: 145–154.
14.
DunbarSBWarnerCDPurcellJA. Internal cardioverter defibrillator device discharge: experiences of patients and family membersHeart Lung1993; 22: 494–501.
15.
MayCSmithPMurdockCDavisM. The impact of the implantable cardioverter defibrillator. Pacing Clin Electrophysiol1995; 18: 1411–1418.
16.
TagneyJJamesJEAlbarranJW. Exploring the patient’s experience of learning to live with an implantable cardioverter defibrillator (ICD) from one UK centre: a qualitative study. Eur J Cardiovasc Nurs2003; 2(3): 195–203.
17.
CarrollDLHamiltonGA. Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock. Heart Lung2005; 34(3): 169–178.
18.
SearsSFContiJB. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. Am J Cardiol2006; 98: 565–567.
19.
ThomasSAFriedmannEKaoCWInguitoPMetcalfMKellyFJ. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care2006; 15(4): 389–398.
20.
WhangWAlbertCMSearsSFLampertRContiJBWhangPJ. Depression as a predictor for appropriate shocks among patients with implantable cardioverter–defibrillators: results from Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol2005; 45: 1090–1095.
21.
MauroAMP. Exploring uncertainty and psychosocial adjustment after cardioveter defibrillation implantation. J Cardiovasc Nurs2008; 23(6): 527–535.
22.
SossongA. Living with an implantable cardioverter defibrillator: patient outcomes and the nurse’s role. J Cardiovasc Nurs2007; 22: 99–104.
23.
DoughertyCM. Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator. Heart Lung1995; 24: 281–291.
24.
KamphuisHCLeeuwRDerksenRHauerRNWinnubstJA. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery. Europace2003; 5(4): 381–389.
25.
SearsSFLewisTSKuhlMAContiJ. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics2005; 46: 451–457.
26.
DunbarSBJenkinsLSHawthorneMKimbleLPDudleyWNSlemmonsM. Factors associated with outcomes three months after implantable cardioverter defibrillator insertion. Heart Lung1999; 28(5): 303–315.
27.
EckertMJoneT. How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families. Int J Nurs Pract2002; 8(3): 152–157.
28.
PiresLASethuramanBGuduguntlaVDToddKMYamasakiHRaviS. Outcome of women versus men with ventricular tachyarrhythmias treated with the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol2002; 13(6): 563–568.
29.
LuysterFHughesJWaechterDJosephsonR. Resource loss predicts depression and anxiety among patients treated with implantable cardioverter defibrillator. Psychosom Med2006; 68(5): 794–800.
30.
SmithGDunbarSBValderramaALViswanathanB. Gender differences in implantable cardioverter defibrillator patients at the time of insertion. Prog Cardiovasc Nurs2006; 21(2): 76–82.
31.
SpindlerHJohansenJBAndersenKMortensenPPedersenS. Gender differences in anxiety concerns about the cardioverter defibrillator. Pacing Clin Electrophysiol2009; 32: 614–621.
32.
HellerSSOrmontMALidagosterLSciaccaRRSteinbergJS. Psychosocial outcome after ICD implantation: a current perspective. Pacing Clin Electrophysiol1998; 21(6): 1207–1215.
33.
Declaration of Helsinki. Br Med J1964; 177: ii.
34.
WareJESherbourneCD. The medical outcome survey 36 item short form health survey. Med Care1992; 30: 473–483.
35.
DuruFBuchiSKlaghoferR. How different from pacemaker patients are recipients of implantable cardioverter defibrillators with respect to psychosocial adaptation, affective disorders and quality of life?. Heart2001; 85(4): 375–379.
36.
SchronEExnerDYaoKJenkinsLSSteinbergJSCookJR. Quality of life in the AVID Trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.. Circulation2002; 105(5): 589–594.
37.
PelletierDGallagherRMitten-LewisSMcKinleySSquireJ. Australian implantable cardioverter defibrillator recipients: quality of life issues. Int J Nurs Pract2002; 8(2): 68–74.
38.
HsuJUratsuCTrumanAQuesenberryCMcDonaldKMHlatkyMA. Life after a ventricular arrhythmia. Am Heart J2002; 144(3): 404–412.
39.
WareJEKosinskiMKellerBK. SF-36 physical and mental health summary scales: a users manual. Boston: New England Medical Centre; 1994.
40.
SpielbergerCDGorsuchRLusheneRVaggPRJacobsGA. Manual for the state trait anxiety inventory (self evaluation questionnaire). Palo Alto, Calif: Consulting Psychologists Press Inc; 1983.
41.
HegelMTGriegelLEBlackCGouldenLOzahowskiT. Anxiety and depression in patients receiving implanted cardioverter defibrillators: a longitudinal investigation. Int J Psychiatry Med1997; 27(1): 57–69.
42.
PauliPWiedemannGDenglerWBlaumann-BenninghoffGKuhlkampV. Anxiety in patients with an automatic implantable cardioverter defibrillator: what differentiates them from panic patients?. Psychosom Med1999; 61(1): 69–76.
43.
BeeryTaBaasLHenthornCMatthewsHBurroughsJHenthornR. Development of the Implanted Devices Adjustment Scale (IDAS). Dimens Crit Care Nurs2005; 242–248.
BurnsJLSerberERKeimSSearsSF. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol2005; 16: 384–390.
46.
BilgeAKOzbenBDemircanSCinarMYilmazEAdaletK. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol2006; 29(6): 619–626.
47.
VasquezLDKuhlEASheaJBKirknessALemonJWhalleyD. Age-specific differences in women with implantable cardioverter defibrillators: an international multicenter study. Pacing Clin Electrophysiol2008; 31: 1528–1534.
48.
RussoAMNayakHVerdinoRSpringmanJGerstenfeldEHsiaH. Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?. Pacing Clin Electrophysiol2003; 26(12): 2289–2295.
